ENO1 and Cancer
- PMID: 35434271
- PMCID: PMC8987341
- DOI: 10.1016/j.omto.2021.12.026
ENO1 and Cancer
Abstract
α-Enolase (ENO1), also known as 2-phospho-D-glycerate hydrolase, is a glycolytic enzyme that catalyzes the conversion of 2-phosphoglyceric acid to phosphoenolpyruvic acid during glycolysis. It is a multifunctional oncoprotein that is present both in cell surface and cytoplasm, contributing to hit seven out of ten "hallmarks of cancer." ENO1's glycolytic function deregulates cellular energetic, sustains tumor proliferation, and inhibits cancer cell apoptosis. Moreover, ENO1 evades growth suppressors and helps tumors to avoid immune destruction. Besides, ENO1 "moonlights" on the cell surface and acts as a plasminogen receptor, promoting cancer invasion and metastasis by inducing angiogenesis. Overexpression of ENO1 on a myriad of cancer types together with its localization on the tumor surface makes it a great prognostic and diagnostic cancer biomarker as well as an accessible oncotherapeutic target. This review summarizes the up-to-date knowledge about the relationship between ENO1 and cancer, examines ENO1's potential as a cancer biomarker, and discusses ENO1's role in novel onco-immunotherapeutic strategies.
Keywords: ENO1; cancer biomarker; glycolysis; hallmarks of cancer; oncotherapy; tumorigenesis.
© 2022 The Authors.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Alpha-Enolase: Emerging Tumor-Associated Antigen, Cancer Biomarker, and Oncotherapeutic Target.Front Genet. 2021 Jan 28;11:614726. doi: 10.3389/fgene.2020.614726. eCollection 2020. Front Genet. 2021. PMID: 33584813 Free PMC article. Review.
-
Progress in the biological function of alpha-enolase.Anim Nutr. 2016 Mar;2(1):12-17. doi: 10.1016/j.aninu.2016.02.005. Epub 2016 Mar 2. Anim Nutr. 2016. PMID: 29767008 Free PMC article. Review.
-
Role of ENO1 and its targeted therapy in tumors.J Transl Med. 2024 Nov 14;22(1):1025. doi: 10.1186/s12967-024-05847-8. J Transl Med. 2024. PMID: 39543641 Free PMC article. Review.
-
ENO1 monoclonal antibody inhibits invasion, proliferation and clone formation of cervical cancer cells.Am J Cancer Res. 2021 May 15;11(5):1946-1961. eCollection 2021. Am J Cancer Res. 2021. PMID: 34094663 Free PMC article.
-
Riboregulation of Enolase 1 activity controls glycolysis and embryonic stem cell differentiation.Mol Cell. 2022 Jul 21;82(14):2666-2680.e11. doi: 10.1016/j.molcel.2022.05.019. Epub 2022 Jun 15. Mol Cell. 2022. PMID: 35709751
Cited by
-
Multi-omics reveals the role of ENO1 in bladder cancer and constructs an epithelial-related prognostic model to predict prognosis and efficacy.Sci Rep. 2024 Jan 25;14(1):2189. doi: 10.1038/s41598-024-52573-8. Sci Rep. 2024. PMID: 38273010 Free PMC article.
-
Diversity of post-translational modifications and cell signaling revealed by single cell and single organelle mass spectrometry.Commun Biol. 2024 Jul 19;7(1):884. doi: 10.1038/s42003-024-06579-7. Commun Biol. 2024. PMID: 39030393 Free PMC article.
-
Emerging Biosensing Methods to Monitor Lung Cancer Biomarkers in Biological Samples: A Comprehensive Review.Cancers (Basel). 2023 Jun 29;15(13):3414. doi: 10.3390/cancers15133414. Cancers (Basel). 2023. PMID: 37444523 Free PMC article. Review.
-
Proteomics Reveals How the Tardigrade Damage Suppressor Protein Teaches Transfected Human Cells to Survive UV-C Stress.Int J Mol Sci. 2023 Jul 14;24(14):11463. doi: 10.3390/ijms241411463. Int J Mol Sci. 2023. PMID: 37511223 Free PMC article.
-
Divergent iron regulatory states contribute to heterogeneity in breast cancer aggressiveness.iScience. 2024 Aug 3;27(9):110661. doi: 10.1016/j.isci.2024.110661. eCollection 2024 Sep 20. iScience. 2024. PMID: 39262774 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
